CFDE Data Portal | Search LOC389199

	Label	Description
	LOC389199 associations Collection (Entity type)	Associations for LOC389199_associations
	LOC389199 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	LOC389199 Gene (Entity type)	ENSG00000228919 - uncharacterized LOC389199
	GSE195663 cisplatin 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE195663 cisplatin 7 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE207410 GSE207411 ARID1A knockdown 5 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE176008 pyridoxine 4 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE146982 metformin 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE207410 GSE207411 ARID1A knockdown 5 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Nerve 20-29 vs 30-39 Down Gene Set (Entity type)	A Gene Set from GTEx

LOC389199 associations

Associations for LOC389199_associations

LOC389199 associations.tsv

A file from IDG as part of the Harmonizome project

LOC389199

ENSG00000228919 - uncharacterized LOC389199

GSE195663 cisplatin 0 v 1 human up

A Gene Set from LINCS

GSE195663 cisplatin 7 v 1 human up

A Gene Set from LINCS

GSE207410 GSE207411 ARID1A knockdown 5 v 3 human up

A Gene Set from LINCS

GSE176008 pyridoxine 4 v 3 human dn

A Gene Set from LINCS

GSE146982 metformin 0 v 1 human up

A Gene Set from LINCS

GSE207410 GSE207411 ARID1A knockdown 5 v 4 human up

A Gene Set from LINCS

GTEx Nerve 20-29 vs 30-39 Down

A Gene Set from GTEx

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.